**Enveric Biosciences to Execute Reverse Stock Split on October 28, 2025**
Enveric Biosciences, Inc. announced plans to implement a reverse stock split of its common stock at a ratio of 1 post-split share for every 12 pre-split shares. This action is aimed at reducing the total number of shares outstanding.
The reverse stock split will become effective at 8:00 a.m. ET on October 28, 2025. As a result, the number of Enveric’s common stock shares outstanding will decrease from approximately 6,219,568 shares to about 518,297 shares.
Following the announcement, ENVB shares were down 5.89% in premarket trading, priced at $0.00.
Stay tuned for more updates on Enveric Biosciences and related market news.
https://seekingalpha.com/news/4507442-enveric-biosciences-to-execute-reverse-stock-split?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Be First to Comment